Detail

Study ID: NRN PDA (Patent Ductus Arteriosus in Premature Infants) Study

Title:

Management of the Patent Ductus Arteriosus in Premature Infants Trial (PDA Trial)

Description:
Title: Management of the Patent Ductus Arteriosus in Premature Infants Trial (PDA Trial) Description: This study will look at a problem called patent ductus arteriosus (PDA). Your infant has a PDA and this is very common in premature babies. A PDA is called “symptomatic” if the baby is also having breathing problems. Some doctors think every baby with a symptomatic PDA should be treated to prevent future breathing problems, this is called active care. Other doctors think that the baby only needs to be treated if the PDA is large and the baby is on the breathing machine. This is called expectant care. In this study, we want to find out if active or expectant care is better.4 Key Inclusion/Exclusion Criteria including Age Range If Applicable:Inclusion: Infant 22 0/7 to 28 6/7 weeks gestation at birth, postnatal age 48 hours to 21 days old with a symptomatic PDA Exclusion: cardiopulmonary compromise, known congenital heart disease, know pulmonary malformation, received prior treatment for symptomatic PDA
Location:
Sioux Falls Region
Principal Investigator:
Baiba Steinbrekera, MD
Disease:
Heart
Stage:
N/A
Status:
Active - Open to Accrual